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The circadian rhythm, controlled by a complex network of cellular transcription factors, orchestrates behavior and physiology in
the vast majority of animals. The circadian system is comprised of a master clock located in central nervous system with 24-hour
rotation and periphery clocks to ensure optimal timing of physiology in peripheral tissues. Circadian expression of peroxisome
proliferator-activated receptors (PPARs), members of the nuclear receptor superfamily and key mediators of energy homeostasis
and metabolism, is regulated by clock genes. PPARs serve as sensors of nutrient and energy/metabolism status to temporally
entrain peripheral clock. Metabolism and circadian clocks are tightly intertwined: clock genes drive metabolism, and various
metabolic parameters aﬀect clock genes, producing a reciprocal feedback relationship. Due to PPARs’ robust relationship with
energy status and metabolism, the aberration of PPARs in the biological clock system leads to abnormal expression of genes in
metabolic pathways, thus, contributing to etiology of metabolic syndrome. Studying PPARs’ functions under the context of the
mammalian circadian system could advance our understanding of how energy and metabolic status are maintained in the body,
which may ultimately lead to rhythmic medical treatment against metabolic syndrome.
1.Introduction
1.1. The Mammalian Circadian Clock. The behavior and
physiology of the vast majority living organisms oscillate
in a 24-hour cycle in response to the light-dark cycle. It
is estimated that 3%–20% of mammalian genes are under
circadian regulation in a tissue-dependent manner [1]. Gene
expression microarray analysis of mouse prefrontal cortex
revealed that approximately 10% of transcripts demonstrate
a diurnal expression rhythm [2]. Among the rhythmic
genes identiﬁed, many have functions in biosynthetic and
metabolic processes [1]. In addition to rhythmic tran-
scriptional regulation of gene expression, various biological
processes including hormone secretion, blood pressure,
sleep-awake pattern, blood glucose and lipid level, body
temperature, and metabolism exhibit circadian oscillation
[3]. This endogenous response has clear implications in
health and disease. For instance, the occurrence of certain
cardiovascular diseases such as stroke, unstable angina, and
myocardial infarction is markedly more frequent in speciﬁc
parts of the day [4–6].
In mammals, the internal biological clocks are composed
of central and peripheral components whose function is
to coordinate biological processes to maintain synchrony
with the environmental cycles of light and nutrients [7–
9]. The central clock or master clock is located in the
suprachiasmatic nuclei (SCN) of the anterior hypothalamus
[10]. The role of the central clock is to coordinate peripheral
oscillators situated in various peripheral tissues such as the
liver, the kidney, the heart, and muscles in such a way that
normal circadian rhythm is maintained at the organismal
level [10, 11].
Light is a major daily external photic resetting signal
of the circadian system in mammals. Through the retino-
hypothalamic tract, light resets the master clock in the
SCN triggering neural and humoral signaling that subse-
quently synchronizes the peripheral clock [8]. Although
the pathways to synchronize an organism at the systemic
level remain poorly understood, a model to explain this
event at the cellular level has been established. Transcription
factors, activators, and repressors are now emerging as clock
components. They form feedback regulatory loops resulting2 PPAR Research
in rhythmic expression of each component and lead to
cascades of gene expression with 24-hour periodicity. The
key players are two transcription factors: brain and muscle
Arnt-like protein 1(Bmal1) and CLOCK/NPAS2 [7], which
form heterodimers to constitute the central loop (Figure 1,
(2)).CLOCKhasintrinsicacetylacetyltransferasetransferase
activity [8] and acetylates its heterodimer partner Bmal1
[8]. The acetylated Bmal1/CLOCK heterodimer then binds
to the E-box (5 -CACGTG-3 ) enhancer elements of Period
genes (Per1, Per2, and Per3) and Cryptochrome gene (Cry1
and Cry2) promoters (Figure 1,( 3 ) )[ 8, 12, 13]t oa c t i v a t e
transcription of Per and Cry [14]. The products of these
genes interact to form repressor complexes which translocate
into the nucleus and inhibit Bmal1-CLOCK/NPAS2 activity,
thus resulting in repression of their own transcription [7].
To sustain the negative feedback loop, multiple components
are subjected to posttranslational regulations. For example,
Per and Cry proteins are regulated by ubiquitin-proteasome
pathways [15], and CLOCK acetyltransferase activity can be
reversed by SIRT1 deacetylase (Figure 1,( 1 ) )[ 8].
In addition to central transcription factors regulating the
central loop, another feedback loop line tunes the activity of
thecoreclockcomponents(Figure 1)[16].Bmal1expression
is controlled by orphan nuclear receptors: retinoid-related
orphan receptor alpha (RORα)a n dR e v - e r b α (NR1D1) [7,
8]. RORα and Rev-erbα are closely related and recognize
similar response elements (RORE) [7]. As a result, they
compete for common RORE in the Bmal1 promoter and
trigger opposing responses [7]. RORα interacts with peroxi-
some proliferator-activated receptor-γ coactivator-1α (PGC-
1α) resulting in histone acetylation and subsequent Bmal1
transcription activation (Figure 1, (8)) whereas Rev-erbα
interacts with corepressors leading to histone deacetylation
and Bmal1 transcription inhibition (Figure 1, (12)) [14].
This RORα/Rev-erbα interplay is believed to be responsible
for Bmal1 rhythmic expression. Reciprocally, Bmal1 and
CLOCK regulate Rev-erbα by binding to the E-box in Rev-
erbα promoter (Figure 1,( 4 ) )[ 7]. Moreover, the promoter
of Rev-erbα also contains RORE rendering it to be negatively
controlled by itself and positively controlled by RORα
(Figure 1, (5) and (6)) [7].
Ar e c e n ts t u d yb yS c h m u t ze ta l .h a si d e n t i ﬁ e dan o v e l
role of Per2 in the regulation of circadian rhythm; that is
acting as cofactors for two nuclear receptors. Per2 was shown
to interact with Rev-erbα at Bmal1 promoter to repress
Bmal1 expression in liver in a Rev-erbα-dependent manner
[17]. In the liver of Rev-erbα−/−/Per2 mutant mice, Bmal1
rhythmic mRNA expression was completely abolished [17].
In a diﬀerent phase, Per2 can be brought to the PPRE region
of Bmal1 promoter by PPARα and functions as a coactivator
to enhance Bmal1 expression. Taken together, Per2 appears
to be a modulator of Bmal1 expression by two circadian
mechanisms:rhythmicrepressionmediatedbyRev-Erbαand
rhythmic activation mediated by PPARα.
Attempts have been made to identify novel regulators
of the biological clocks. A recent study employing genome-
wide RNAi screening has identiﬁed ∼1000 genes of which
knockdown resulted in amplitude reduction, and hundreds
of genes of which knockdown altered oscillation period
length or increased amplitude [18]. Pathway analysis of
newly identiﬁed genes has shown that many of these genes
participate in insulin signaling, hedgehog signaling, cell cycle
regulation, and folate metabolism [18], exemplifying the
involvement of biological clocks in the regulation of cellular
metabolism, growth, and development. Several reviews have
discussed the molecular mechanisms of biological clocks in
greatdetails[3,8,13],thusarereferredtoforfurtherreading.
1.2. PPARs Overview. Peroxisome proliferator-activated
receptors (PPARs) are a subfamily of the nuclear receptor
superfamily of transcriptional factors [19]. The PPAR
subfamily constitutes three members: PPARα,P P A R β/δ
and PPARγ [19–21]. Despite a high degree of homology
observed among PPARs, each isoform possesses distinct
biological activities [20] and is expressed in diﬀerent
tissues [19, 21, 22]. PPARα is mainly expressed in the liver,
the kidney, and the heart, and is primarily involved in
lipid metabolism [22–24]. PPARγ is a master regulator of
adipogenesis and fat storage, which regulates adipocyte
diﬀerentiation and insulin sensitivity in adipose tissue
[22–24]. PPARβ/δ i sf o u n di nab r o a dr a n g eo ft i s s u e sw i t h
relatively high expression in brain, adipose tissue, and skin,
but its function awaits further exploration [22–24]. Taken
together, PPARs are key mediators of energy homeostasis,
and lipid and glucose metabolism although they have also
been associated with other biological processes including
development, diﬀerentiation, inﬂammation, atherosclerosis,
wound healing, and tumor formation [19, 21]. To date,
PPARα and PPARγ are reported to possess signiﬁcant
clinical value. PPAR isoform-speciﬁc agonists, speciﬁcally
ﬁbrates for PPARα and thiazolidinedione for PPARγ,a r e
currently prescribed as lipid and glucose-lowering drugs,
respectively [23]. Interestingly, recent data have shown that
expression of all three forms of PPARs displays circadian
rhythm [22]. Hence, the interdependence of circadian and
metabolic systems jointly regulated by PPARs appears to be
disease relevant and thus, is the focus of this paper.
2. ReciprocalRegulation: Interplay
betweenCentralCircadianSystemand
PPARs in Peripheral Tissues
PPARs act as molecular links between clock genes and
speciﬁc rhythmic metabolic outputs. Emerging evidence has
shown that, in peripheral tissues, PPARs and the core clock
genes cross-regulate each other at transcription level. On
one hand, the circadian expression of PPARα is regulated
by core clock genes and clock-controlled genes (Figure 1,
(10)) [25–28]. On the other hand, it was shown that
PPARs could directly aﬀect circadian transcription of clock
genes (Figure 1,( 9 ) )[ 26, 29, 30]. The expanding regula-
tory network between PPARs and CLOCK proteins opens
new perspectives for understanding the interdependence of
PPARs and the core clock in peripheral tissues.
2 . 1 .T h eM a s t e rC l o c kG e n eP r o d u c t sR e g u l a t eT r a n s c r i p t i o n
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Figure1:RegulatorynetworksofthecoreclockcomponentsandPPARs.(1)Bmal1isacetylatedbyCLOCKwhichpossessesacetyltransferase
activity. This process can be reversed by SIRT1 deacetylase activity. Acetylated Bmal1 and CLOCK proteins heterodimerize (2) translocate
into nucleus and activate transcription of Per, Cry (3), and Rev-erbα (4). In turn, Per and Cry form a repression complex which, upon
translocation from the cytoplasm into the nucleus, inhibits transcription driven by CLOCK/Bmal1, including its own, constituting the main
feedback loop. Bmal1 expression is controlled by Rev-erbα and RORα, the two primary players in the secondary loop, in an opposing
manner. Upon binding to a common RORE, Rev-erbα suppresses transcription (12) while RORα exerts transcriptional activation of Bmal1
(8). The expression of Rev-erbα is driven by CLOCK/Bmal1 (4) and RORα (5) and suppressed by itself (6). PPARs and the core clock
proteins reciprocally regulate each other. PPARs regulate the transcription of some clock genes, for example, PPARα activates Rev-erbα (7)
and Bmal1 (9) while PPARγ only activates Bmal1 transcription (9). On the other hand, clock genes regulate expression levels of PPARs.
CLOCK/Bmal1 drives PPARα expression (10) and Rev-erbα activates transcription of mir-122 (11), a microRNA which downregulates
expression of PPARβ/δ posttranscriptionally.4 PPAR Research
core clock gene products in peripheral tissues. CLOCK, one
of the key components in the circadian regulatory network,
directly controls the circadian expression of PPARα. In wild-
type mice, PPARα expression displays diurnal variation in
the liver [25, 31–34]. However, this rhythmic expression of
PPARαis abolished in the liver of CLOCK-mutant mice [25].
Furthermore, in contrast to the ﬁbroblasts obtained from
normal mice, ﬁbroblasts from CLOCK-mutant mice exhib-
ited decreased expression level and oscillation amplitude of
PPARα in response to oscillation inducer Endothelin-1 (ET-
1) [35]. These ﬁndings indicate that CLOCK controls the
circadian expression of PPARα at the peripheral oscillator
level. Sequence analysis revealed an E-box-rich region in
exon 2 of the mouse PPARα gene [25]. Chromatin immuno-
precipitation (ChIP) of CLOCK in NIH3T3 cells indicates
that CLOCK interacts with this E-box-rich region [25],
suggesting that CLOCK might activate PPARα transcription
by interacting with E-Box in the exon 2 of PPARα. Using
a reporter construct constituting of E-box-rich region of
PPARα fused to luciferase, CLOCK and Bmal1 were shown
to increase transcription by more than 25 folds [25]. E-
Boxes are also present in human PPARα gene (Figure 1, (10))
[25]. Moreover, Bmal1, another component of biological
clock, was also shown to aﬀect PPARα circadian variation
[26]. Furthermore, PPARα mRNA expression was severely
downregulated in the liver of Bmal1−/− mice. Collectively,
theseresultssuggestthatPPARαisadirecttargetgeneofcore
clock proteins CLOCK/Bmal1.
In addition to directly controlling the level of PPARs,
CLOCK/Bmal1 can potentiate PPARs-mediated transcrip-
tion activation. CLOCK/Bmal1 heterodimers have been
shown to increase the transcriptional activity of genes whose
promoter contains PPAR response elements (PPREs) [27].
Increased transcriptional activity was further enhanced by
treatment with PPAR agonists (i.e., fenoﬁbrate for PPARα
and troglitazone for PPARγ)[ 27]. When PPRE was removed
from the promoter, CLOCK/Bmal1 exhibited no eﬀects
on transcription [27], suggesting that the potentiation of
transcription by CLOCK/Bmal1 is dependent on PPAR.
However, the mechanism of CLOCK/Bmal1 and PPARs’
synergistic regulation of gene expression remains to be
explored.
A recent paper provides a novel link between PPARβ/δ
and Rev-erbα, an orphan nuclear receptor and central
regulator of the clock gene. Rev-erbα was shown to maintain
thecircadianexpressionofmir-122,amicroRNAabundantly
foundinhepatocytes,possiblyviatwoROREsinitspromoter
(Figure 1)[ 28]. mir-122 subsequently downregulates target
genes by binding to a complementary sequence located
in 3  untranslated region (3  UTR) [28]. Using reporter
assays, mir-122 was shown to down-regulate PPARβ/δ [28].
FurtherinvestigationisneededtoﬁrmlyestablishthemiRNA
mediated regulation of PPARβ/δ by Rev-erbα.
2.2. PPARs Regulate the Peripheral Clock: A Role of Food
Entrainment. PPARs are not only metabolic sensors but
also circadian clock regulators. In the SCN of the PPARα-
null mice, clock genes (Bmal1, Per2, Per3, Cry2, and Rev-
erbα) exhibited normal diurnal variation [26]. Moreover,
bezaﬁbrate, a PPARα agonist, did not aﬀect circadian
expression of Per2, a core clock gene, in the SCN [29]. These
ﬁndings indicate that PPARα is not essential for maintaining
the normal central clock oscillation. The peripheral clock,
on the other hand, was aﬀected by PPARα expression.
Changes in Bmal1 and Per3 expression was observed in the
livers of PPARα-null mice. Although the overall oscillation
phase remained unperturbed, the amplitude of Bmal1 was
decreased while Per3 amplitude was increased signiﬁcantly
[26] .C i r c a d i a nr h y t h mi np e r i p h e r a lt i s s u e ss u c ha sl i v e r
can be reprogrammed, also termed entrainment, by feeding
cycle alteration [36, 37]. Like other nocturnal animals,
mice normally feed at night. Phases of the mouse liver
PPARα circadian expression could be inversed by daytime
feeding [26]. In wild-type mice, clock genes (Bmal1, Per1,
Per3, and Rev-erbα) showed inversed phase in response
to daytime feeding corresponding to altered expression
of PPARα [26]. However, in PPARα-null mice, although
other clock genes can still be reset, Bmal1 was irresponsive
to daytime feeding triggered by circadian reprogramming,
suggesting that Bmal1 expression is controlled by PPARα
[26]. Furthermore, PPARα-agonist fenoﬁbrate could reset
rhythmic expression and increase transcription of Bmal1,
Per1, Per3, and Rev-erbα in livers of wild-type mice but
failed to induce Bmal1 and Rev-erbα in livers of PPARα-null
mice, indicating that upregulation of Bmal1 and Rev-erbα
by fenoﬁbrate was mediated through PPARα [26]. Another
PPARα agonist, bezaﬁbrate, was shown to stimulate phase
advancement of Per2 circadian expression in peripheral
tissues [29]. ChIP analysis reveals that PPARα directly binds
to PPREs located at 1519 and 45 base pairs upstream of
the transcription initiation site in Bmal1 and Rev-erbα pro-
moters, respectively, [26]. Therefore, PPARα could directly
regulate transcription of Bmal1 and Rev-erbα via binding
to PPREs in their respective promoter regions (Figure 1,
(7)). Moreover, Per2 was shown to further enhance PPARα-
mediatedactivationofreportergenefusedtoPPREinadose-
dependent manner, suggesting that Per2 might function as a
coactivator of PPARα [17]. However, further investigations
are necessary to validate this novel relationship.
Similar to its family members, PPARγ can also mod-
ulate expression of biological clock components. PPARγ
rhythmic expression has been shown to precede that of
Bmal1 in mice blood vessels [30]. Knocking down of PPARγ
abolishes rhythmicity of Bmal1, Cry1, Cry2, and Per2 in
mice aorta [30]. The PPARγ-agonist rosiglitazone induces
Bmal1 expression (Figure 1,( 9 ) )[ 30]. ChIP analysis reveals
that PPARγ also interacts with PPRE in Bmal1 promoter
[30]. In reporter assays employing RORE-containing Bmal1
promoter segment, rosiglitazone treatment resulted in an
increase in promoter activity, which was abolished when
PPRE is mutated [30]. Taken together, PPARγ appears to be
a major regulator of Bmal1 expression in blood vessels.
In summary, the central circadian clock components and
PPARs exhibit a reciprocal regulation. Circadian clock pro-
teins control PPARs expression by at least two mechanisms:
( 1 )a c t i v a t i o no fP P A R α transcription by CLOCK/Bmal1
heterodimer upon binding to the E-box in the PPARαPPAR Research 5
promoter and (2) downregulation of PPARβ/δ by microRNA
stimulated by Rev-erbα. On the other hand, PPARs regulate
the expression of clock genes via two diﬀerent mechanisms
as well: (1) Rev-erbα is positively regulated by PPARα;( 2 )
Bmal1ispositivelyregulatedbybothPPARαandPPARγ.The
multivariable regulatory loops of the core clock proteins and
PPARs are diagrammatically summarized in Figure 1.
2.3. PPAR Cofactors in Circadian Rhythm
2.3.1. NcoR1 and Hdac3. In the absence of ligand, PPARs
form a multicomponent complex with corepressors, such
as nuclear receptor corepressor 1 (NcoR1) [38]. Histone
deacetylase 3 (Hdac3), a histone modiﬁcation enzyme, is
recruited and stably bound to the repressor complex through
a conserved deacetylase activation domain (DAD) in NcoR1
[39]. Hdac3 remodels chromatin in a way less favorable
for access by basal transcriptional machinery, leading to
the repression of PPAR-mediated transcription activation
[38]. NcoR1 is directly involved in the biological clock
system as a cofactor for Rev-erbα. Upon binding to RORE
in the Bmal1 promoter, Rev-erbα recruits NcoR1/Hdac3
to suppress expression of Bmal1 [40]. NcoR1 and Hdac3
are critical for the regulation of clock genes and energy
metabolism homeostasis. A mouse line was generated to
harboramutationinNcoR1DADdomainthatabolishedthe
ability of NcoR1 to interact with or activate Hdac3 [39]. In
NcoR1 mutant knock-in mice, uncoupling of NcoR1 from
binding to Hdac3 led to altered circadian rhythmicity [39].
Bmal1 expression level was higher in the mutant mice than
that of wild-type [39]. This is consistent with the established
corepressor function of NcoR1/Hdac3 for Rev-erbα which
downregulates Bmal1. Circadian expression abnormality of
Bmal1 and Rev-erbα was also observed in these mutant mice
[39].Moreover,themutantmiceexhibitedalteredexpression
patterns of liver genes involved in lipid metabolism. Phase
shifts were observed with genes harboring fat catabolism
function such as carnitine palmitotransferase 1a (Cpt1a),
median chain aryl-CoA dehydrogenase (MCAD), and their
regulator PPARα [39]. ATP citrate lyase (Acly) and acetyl
CoA carboxylase2 (Acc2) displayed phased reversion [39].
Expressionlevelofelongationoflong-chainfattyacidsfamily
member6(Elovl6)wasdecreasedbyfourfoldinmutantmice
as compared with wild-type mice [39], which might explain
the increased leanness and insulin sensitivity. The mutant
mice demonstrated distinct, seemingly desirable pheno-
type including increased leanness, decreased body weight,
reduced body fat, increased O2 consumption, increased body
heat generation, and improved insulin sensitivity [39]. Thus,
uncoupling NcoR1/Hdac3 interaction could be beneﬁcial for
metabolic syndrome management.
2.3.2.PPARγ Coactivator 1α(PGC-1α). Itisbelievedthatlig-
andbindingtoPPARtriggersaconformationalchangewhich
allows the dissociation of corepressors and recruitment of
coactivators that many of which are known to be histone
acetyltransferases (HATs) [41], resulting in transcription
activation of target genes. PPARγ coactivator-1α (PGC-1α),
as the name implies, is a known coactivator of PPARs
[20]. In addition to PPARs, PGC-1α is capable of activating
o t h e rn u c l e a rr e c e p t o r ss u c ha st h y r o i dr e c e p t o rb ,e s t r o g e n
receptor and glucocorticoid receptor TRβ,E R ,a n dG R[ 42].
PGC-1αiswellcharacterizedtobeapartofthebiological
clock. PCG-1α positively regulates the expression of clock
components, including CLOCK, Bmal1, and Rev-erbα [43].
PGC-1α can physically interact with RORα and RORγ
through the LXXLL motif and enhance RORα transcription
activity [43]. When PGC-1α is recruited to the ROR-
bound promoter, it could recruit p300 and GCN5 histone
acetyltransferase to modify local chromatin structure to be
permissive to transcriptional machinery [43]. On the Bmal1
promoter, PGC-1α binding is accompanied by an increase in
histone H3 acetylation and histone 3 lysine 4 trimethylation
(H3K4me3),twomarkersoftranscriptionalactivation,while
histone 3 lysine 9 dimethylation (H3K9me2), a marker
that signiﬁes transcription silencing, decreased [43]. Taken
together, PGC-1α is a coactivator of RORα which converts
chromatin from a quiescent to transcriptionally permeable
state thus enhancing transcription. Disruption of PGC-1α
leads to alteration in locomotor behavior, O2 consumption,
and expression pattern of metabolic genes and clock genes
circuitry [43]. Thus, PGC-1α serves as a potential factor
which couples circadian rhythm to energy status.
3. MedicalImplications: Metabolic Syndrome
andOther DiseasesPotentiallyLinkedto the
AberrantPPAR CircadianRhythm
3.1. Circadian Oscillation of PPARs Displays a Strong Associ-
ation with the Energy and Metabolism Homeostasis. PPARs
play essential functions in energy homeostasis. Circadian
oscillation of PPARs is essential for the temporal coordina-
tion of genes involved in energy and metabolic processes.
PPARα exerts a strong impact on lipid metabolism. Dis-
ruption of PPARα resulted in alteration of the circadian
expression of these metabolism-related genes [44]. Interest-
ingly, the expression patterns of the lipolytic genes appear to
oscillate in-phase with those of PPARα, while those of the
lipogenic genes oppose the expression pattern of PPARα.I n
mouse, the mRNA level of cytosolic acyl-CoA thioesterase
(CTE-I), an enzyme catalyzing lipid hydrolysis, exhibits
diurnal rhythm parallel to the circadian PPARα expression.
TheexpressionofCTE-Icanbeinducedbyfasting;thatisthe
expression is increased during the light phase and declined
duringthedarkphasewhenfeedingactivityisabundant[44].
The fasting-induced CTE-I mRNA level is lower in PPARα-
null mice than that in the normal mice [44], suggesting that
CTE-I diurnal rhythm is regulated through PPARα. In wild-
type but not in PPARα-mutant mice, the administration
of the PPARα-agonist bezaﬁbrate could induce circadian
expression of ﬁbroblast growth factor 21 (FGF21) [34], a
hormone involved in lipolysis and hepatic ketogenesis [45],
suggesting that bezaﬁbrate-induced circadian eﬀect is strictly
PPARα-dependent.
On the contrary, the expression of enzymes involved
in lipid synthesis such as fatty acid synthase (FAS) and6 PPAR Research
acetyl Co-A decarboxylase (ACC) in the fatty acid synthesis
pathway and 3-hydroxyl-3-methylglutaryl-CoA reductase
(HMG-CoAR) in cholesterol synthesis pathway oppose the
expression patterns of PPARα. These enzymes exhibited
increased expression during dark phase in mice [32]. Again,
the circadian expression of these enzymes is abrogated in
PPARα-null mice [32], indicating that the diurnal variation
of these enzymes requires PPARα.
There is evidence suggesting that the feeding behavior is
mediated, in part, by PPARα. Oleoylethanolamide (OEA),
a naturally-produced lipid compound found in mammals
including humans, is a satiety stimulator [46]. Later, OEA
was shown to be a PPARα agonist and displayed circadian
expression [47]. Administration of OEA analogues can
suppress feeding and decrease weight gain in wild-type mice
[47]. However, this response was not observed in PPARα-
null mice [47], indicating that OEA regulates satiety through
activation of PPARα. Nonetheless, the detailed mechanism
by which OEA regulates circadian oscillation remains to be
elucidated.
PPARβ/δ has been linked to regulation of body tem-
perature and lipid proﬁle. PPARβ/δ activates genes involved
in fatty acid oxidation, resulting in increased lipolysis in
adipocyte and skeletal muscle cells [48]. Expression of
PPARβ/δ triggers lipolysis in brown adipose tissue, a body
compartment which is central to adaptive thermogenesis,
during which processed energy is dissipated as heat via
uncoupling proteins (UCPs) [48]. PPARβ/δ expression cycle
has been shown to oscillate in-phase with that of uncoupling
protein 1(UCP1) [22], suggesting that PPARβ/δ could
promoteenergydissipation.However,thisrelationshipneeds
to be validated experimentally.
In conclusion, PPARs serve as sensors which integrate
energy and metabolic homeostasis to circadian clock. There-
fore, the aberration of clock genes could result in altered
expression of metabolic genes, leading to disturbance of
energystatus in aﬀectedorganisms. Thisimbalanceisknown
to attribute to metabolic syndrome, a complex disease with
distinct hallmarks including obesity, dyslipidemia, hyper-
tension, and elevated plasma glucose level [49]. Further
experiments investigating this relationship could deepen our
understandingofpathogenesis,whichmaypavewaysfornew
strategies to ﬁght against metabolic syndrome.
3.2. Eﬀect of Gender on the Biological Clock and PPARs
Expression. Clinically, patients with comparable health are
usually administered the same treatment regimen, regardless
of gender. However, with the emerging idea of individualized
medication, gender might need to be taken into account.
Experiments in mice revealed distinct expression patterns
of clock genes in the liver and hepatic lipid homeostasis
diﬀerences between males and females [50]. The majority
of hepatic clock genes including CLOCK, Bmal1, Per1, Per2,
Cry1, and Rev-erbα reached mRNA peaks 30 minutes earlier
in female as compared to male mice, while Cry2 and Per3
peaked earlier in male than female mice [50]. Statistically
calculated mean expression levels of Per1, Per3, and RORα
were also higher in female mice [50] as well as the amplitude
of Cry1 and Per3 [50]. Similarly, PPARs and their coactiva-
tors showed diﬀerential expression between the two genders.
PPARα,P P A R β/δ, and PGC-1β expression peaked at least 30
minutes earlier in female mice [50]. Statistically calculated
mean expression levels of PPARα,P G C - 1 α and PGC-1β
were higher in female mice than the male counterparts
[50]. Moreover, the expression pattern of genes involved
in lipid metabolism, triglyceride and cholesterol proﬁles
in liver and serum of male and female mice ﬂuctuated
diﬀerently throughout the day [50]. Taken together, these
ﬁndings implicate gender associated disparity of clock gene
rhythmicity, expression patterns of genes involved in energy
homeostasis, and serum hepatic lipid proﬁle. Since these
diﬀerences could potentially aﬀect the eﬃcacy of drugs that
target circadian clock and lipid metabolism, several issues
are worth noting. Should drug administration be tailored
speciﬁcally for males and females based on these diﬀerences?
Can this intervention increase eﬃcacy or reduce untoward
eﬀects of mediation? Further studies would be necessary to
provide concrete solutions.
3.3. Other Circadian Physiology with PPARs Involvement:
Stress, Sleep-Awake Cycle, and Blood Pressure. Circadian
clocksessentiallyregulaterhythmiccellularandphysiological
processes, providing a platform for communications among
diﬀerent physiological processes. It is worthy of noting that
PPARsareamonganumberofnuclearreceptorsthatmediate
the connections between circadian clocks and physiological
processes. The functions of nuclear receptors in regulating
circadian clock and physiology have been extensively dis-
cussed in several recent papers [51, 52] thus this paper will
focus on PPARs. Besides their major roles in regulating lipid,
glucose, and energy metabolisms, PPARs are also involved in
regulating behavior rhythm and other physiological rhythms
such as body temperature, blood pressure, and sleep phase.
As the endocrine system is also involved in clock entrain-
mentbymetaboliccues,thereisfunctionalcrosstalkbetween
PPARs and endocrine system. Aside from the nutrient status,
PPARα level is regulated by oscillation of steroid hormones.
In mice, PPARα gene expression is positively controlled by
glucocorticoids[31,53,54],stresshormoneswhosesecretion
displays diurnal rhythm [31]. Mice PPARα mRNA and
protein levels were also shown to oscillate in-phase with
plasma corticosterone [31], suggesting that PPARα might
play a role in the stress response.
PPARα has been implicated in regulating behavior
rhythm such as sleep-wake cycle. Locomotor activity of
mice with delayed sleep phase syndrome (DSPS), a disease
described by persistent delayed sleep onset, can be restored
by bezaﬁbrate administration, implicating that bezaﬁbrate
may be a putative drug for DSPS treatment [29].
PPARs are also sensors of environmental cues to orches-
trate distinct physiological rhythms such as body temper-
ature, heart rate, and blood pressure. Mice with PPARγ
deletion exhibits abnormal blood pressure and heart rate
circadian rhythm, in accordance with decreased diurnal
variation in sympathetic activity [30]. Alteration in circadian
expression pattern of vascular Bmal1 has been observed inPPAR Research 7
External cues Clock oscillator Cellular signaling Human diseases
Light
Food
PPARs
Expression of genes
involved in
metabolism and
energy homeostasis
SCN master clock
peripheral clocks Metabolic syndrome
- Stress response
- Blood pressure
- Sleep-awake cycle
Figure 2: Overview of the functional link between the biological clocks and PPARs in health and disease. The external cues such as food and
light can program SCN and peripheral clocks, leading to corresponding orchestrated expression of genes involved in metabolism and energy
homeostasis. The gene products of clock components and PPARs reciprocally regulate each other, while both exhibit gender diﬀerence.
Aberration in the biological clock-PPARs network is causative of metabolic syndrome and may also be responsible for human disorders
including stress response, blood pressure, and sleep-awake cycle.
these mice [30], implicating the involvement of Bmal1 in
cardiovascular physiology.
In summary, the biological clock is a self-sustained regu-
latory system which, under normal circumstance, allows ap-
propriate acclimation of body physiology such as metabolic
rate, blood pressure, and alertness to the immediate envi-
ronment. In order to maintain homeostasis, environmental
factors, by large light and food, trigger signal transduction
to synchronize the circadian clock resulting in appropriate
expression of downstream genes. Our paper exempliﬁes the
bidirectional regulatory loop between PPARs and circadian
clock. Together, PPARs and the biological clock play roles
in maintenance of the expression of metabolic genes in
response to the surrounding environment. Due to its strong
association to energy status, deregulation of the PPARs-
circadian clock system is believed to contribute, at least in
part, to the development of metabolic syndrome. Further-
more, emerging evidence also suggests that disturbance in
the PPAR-circadian clock system could aﬀect various aspects
of physiology including stress response, blood pressure, and
sleep-awake cycle (Figure 2). Thus the disease link between
PPARs and the circadian clock has become an exploratory
area of PPARs research.
4. Conclusion
Circadian rhythm is essential for coordination of physiol-
ogy and behavior in living organisms to respond to the
immediate environment in a timely manner. Specialized
proteins including CLOCK, Bmal1, Per, Cry, RORα,a n d
Rev-erbα are responsible for the assembly of a complex
regulatory system that possesses self-sustained circadian
oscillation capacity in the circuit. PPARs in peripheral tissues
exhibit a strong interplay with the central circadian clock
components, serving both as aﬀecters and eﬀecters of the
clock system. We diagrammatically summarize the biological
clock transcriptional regulatory networks (Figure 1)a n d
the functional roles of PPARs (Figure 2) in the context of
circadian regulation. Since the major function of PPARs is
to regulate metabolism and energy homeostasis, it seems
plausible that PPARs are critical players to coordinate energy
status of an organism to the central biological clock. Thus,
dissecting the functional roles of PPARs in circadian rhythm
couldpotentiallyadvanceourunderstandingonmechanisms
of disorders in energy homeostasis and metabolism.
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